Citation Impact
Citing Papers
Risk Factors for Venous Thromboembolism
2003 Standout
Aspirin use and chronic diseases: a cohort study of the elderly.
1989
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report
1969
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Myopia
2012 Standout
Diabetic retinopathy
2010 Standout
Inhibitors of Ocular Neovascularization
2005
Active myocardial damage without attending inflammatory response in dilated cardiomyopathy
1993
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Risk and maintenance factors for eating pathology: A meta-analytic review.
2002 Standout
Age-Related Macular Degeneration
2008 Standout
Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up
2007
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies
1993
The longitudinal course of marital quality and stability: A review of theory, method, and research.
1995 Standout
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
1995 Standout
A simulation study of the number of events per variable in logistic regression analysis
1996 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
2002 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Sustained delivery of a HIF-1 antagonist for ocular neovascularization
2013 StandoutNobel
Macular pigment and age related macular degeneration
1999
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
From mice to men: What can we learn about personality from animal research?
2001 Standout
Adiponectin Levels and Risk of Type 2 Diabetes
2009 Standout
Alcohol and Eye Diseases
2008
The Lens Opacities Case-Control Study
1991
The Relationship of Ocular Factors to the Incidence and Progression of Age-Related Maculopathy
1998
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Myocarditis
2000 Standout
Behavioral syndromes: an ecological and evolutionary overview
2004 Standout
Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality
1994 Standout
Meta-analysis of Epidemiologic Dose-Response Data
1993
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
1996
Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives
2005
Coagulase-Negative Staphylococcal Bacteremia
1989
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Breast cancer metastasis: markers and models
2005 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Risk of bias versus quality assessment of randomised controlled trials: cross sectional study
2009
On the Use of Surrogate End Points in Randomized Trials
2000
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Assessing agricultural risks of climate change in the 21st century in a global gridded crop model intercomparison
2013 Standout
European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
1984
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Menopausal Estrogen Replacement Therapy and Breast Cancer
1991
Aspirin Use and Reduced Risk of Fatal Colon Cancer
1991 Standout
A growth curve approach to the measurement of change.
1982
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Base Logic: Tests of Baseline Balance in Randomized Clinical Trials
1995
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Assessment of the epidemiological data relating lung cancer to air pollution.
1983
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.
1993 Standout
The status of risk factors and coronary heart disease
1970
Menopausal estrogen use and the risk of breast cancer
1986
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Ocular Associations of Diabetes Other Than Diabetic Retinopathy
2008
Surrogate End Points in Clinical Trials: Are We Being Misled?
1996
Socioeconomic status and obesity: A review of the literature.
1989 Standout
The Hypercoagulable States
1985
Dietary Carcinogens and Anticarcinogens
1983 StandoutScience
Questions and Answers in the Measurement of Change
1988
A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer
1991
Studies of male survivors of myocardial infarction. XII. Relation of serum lipids and lipoproteins to survival over a 10-year period.
1970
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Estrogen use and breast cancer interaction with body mass
1983
Mediation in experimental and nonexperimental studies: New procedures and recommendations.
2002 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
Epidemiology of Venous Thromboembolism
1977
Individual behavioural characteristics in pigs
1993
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Are There Two Logistic Regressions for Retrospective Studies?
1978
Studies on the reliability of vital and health records: I. Comparison of cause of death and hospital record diagnoses.
1979
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Mediation Analysis
2006 Standout
The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns
1980
Variation in height and weight in the Norwegian population.
1971
Nifedipine
1995 Standout
Oestrogen therapy after the menopause — boon or bane?
1988
Self-administration of a questionnaire on chest pain and intermittent claudication.
1977
Consensus measurement in Delphi studies
2012 Standout
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Works of Daniel Seigel being referenced
Studies of disease among migrants and native populations in Great Britain, Norway, and the United States. 3. Prevalence of cardiorespiratory symptoms among migrants and native-born in the United States.
1966
Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion
1998
Surrogate endpoints in clinical trials: Ophthalmologic disorders
1989
Acceptable Values of Kappa for Comparison of Two Groups
1992
Senile Lens and Senile Macular Changes in a Population-Based Sample
1980
MULTIPLE RELATIVE RISK FUNCTIONS IN CASE-CONTROL STUDIES1
1973
Pregnancy, the Puerperium and the Steroid Contraceptive
1972
Lens Opacities and Senile Maculopathy
1981
Should Data Be Collected on a Dependent Variable Late in a Clinical Trial if Not Measured at Baseline?
1989
Prevalence at death. II. Methodological considerations for use in mortality studies.
1968
Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report #13.
1989
Validity in estimating relative risk in case-control studies
1973
Oral contraceptives and mortality trends from thromboembolism in the United States.
1969
Aspirin and Cataracts
1982
Several Approaches for Measuring Average Rates of Change for a Second Degree Polynomial
1975
A critique of studies of long-term survivorship of patients with a myocardial infarction.
1968
An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use
1979